Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection

dc.creatorValdivieso, F
dc.creatorVial, P
dc.creatorFerres, M
dc.creatorYe, CY
dc.creatorGoade, D
dc.creatorCuiza, A
dc.creatorHjelle, B
dc.date.accessioned2024-01-10T12:40:47Z
dc.date.available2024-01-10T12:40:47Z
dc.date.created2024-01-10T12:40:47Z
dc.date.issued2006
dc.identifier10.3201/eid1201.050930
dc.identifier1080-6059
dc.identifier1080-6040
dc.identifierMEDLINE:16494739
dc.identifierhttps://doi.org/10.3201/eid1201.050930
dc.identifierhttps://repositorio.uc.cl/handle/11534/77349
dc.identifierWOS:000234419700033
dc.description.abstractWe evaluated titers of homotypic and heterotypic neutralizing antibodies (NAbs) to Andes and Sin Nombre hantaviruses in plasma samples from 20 patients from Chile and the United States. All but 1 patient had high titers of NAb. None of the plasma samples showed high titers against the heterologous virus.
dc.languageen
dc.publisherCENTERS DISEASE CONTROL
dc.rightsacceso restringido
dc.subjectCARDIOPULMONARY SYNDROME
dc.subjectINTRAVENOUS RIBAVIRIN
dc.subjectPULMONARY SYNDROME
dc.subjectHEMORRHAGIC-FEVER
dc.subjectDOUBLE-BLIND
dc.subjectVACCINATION
dc.subjectAMERICA
dc.subjectTRIAL
dc.subjectMODEL
dc.titleNeutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection
dc.typeartículo


Este ítem pertenece a la siguiente institución